Analysts' recommendations: Avinger, Inc.

23-04-21	HC Wainwright Starts Avinger at Buy With $1.60 Price Target	MT
22-05-11	B. Riley Lowers Avinger's Price Target to $9 from $11, Keeps Buy Rating	MT
22-03-18	B. Riley Adjusts Avinger's Price Target to Post-Split $11 from $40, Expects Omicron Impact Late in Q4, Into Q1; Keeps Buy Rating	MT
21-06-29	AVINGER : B. Riley Starts Avinger at Buy with $2.50 PT, Says Well-Positioned to Execute on Growth Strategy	MT

More recommendations

Managers and Directors: Avinger, Inc.

Manager	Title	Age	Since
Karina Yamamoto CEO	Chief Executive Officer	-	-
Thomas Davis CTO	Chief Tech/Sci/R&D Officer	-	2024-08-04

More insiders

Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Nasdaq Other stock markets 16:00:00 2025-02-14 EST			5-day change	1st Jan Change
0.4740 ^USD	-20.74%		-.--%	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI

Market Cap	2.71M 2.38M 2.21M 2.03M 3.81M 262M 3.88M 26.45M 10.32M 128M 10.16M 9.94M 444M	P/E 2022	-0.25x	P/E 2023	-0.19x
Enterprise Value	12.83M 11.28M 10.48M 9.64M 18.08M 1.24B 18.4M 125M 48.88M 606M 48.16M 47.11M 2.1B	EV / Sales 2022	1.19x	EV / Sales 2023	1.78x
Free-Float	88.44%	Yield 2022 *	-	Yield 2023	-

25-02-19	Avinger, Inc.(NasdaqCM:AVGR) dropped from S&P TMI Index	CI
25-02-16	Avinger, Inc.(NasdaqCM:AVGR) dropped from NASDAQ Composite Index	CI
25-02-10	Avinger Inc Terminated Employment Of Each Of Jeffrey M. Soinski, Co's CEO And Nabeel Subainati, Vice President, Finance	RE
25-02-10	Avinger, Inc. Announces Termination of the Employment of Jeffrey M. Soinski, Chief Executive Officer	CI
25-02-10	Avinger, Inc. Announces Executive Changes	CI
24-12-24	Wall Street Set to Open Mixed Tuesday Ahead of Holiday Break	MT
24-12-24	US Futures Tread Water Ahead of Holiday Break	MT
24-12-23	Iberdrola Completes Merger with Avangrid	MT
24-11-07	Avinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI
24-11-07	Earnings Flash (AVGR) AVINGER Reports Q3 Loss $-1.82	MT
24-11-07	Earnings Flash (AVGR) AVINGER Posts Q3 Revenue $1.7M	MT
24-11-07	Avinger, Inc., Q3 2024 Earnings Call, Nov 07, 2024
24-10-04	Wall Street Set to Open Higher Friday on Strong Employment Data	MT

25-01-02	Avinger : Private Placement Form 8 K	PU
24-11-07	Avinger : Quarterly Report for Quarter Ending September 30, 2024 (Form 10-Q)	PU
24-11-07	Avinger : Reports Third Quarter 2024 Results Form 8 K	PU
24-11-07	Avinger: Q3 Earnings Snapshot	AQ
24-10-25	Avinger Releases Updated Data from IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention	AQ

Avinger, Inc. Stock

Stocks

AVGR

US0537348775

Advanced Medical Equipment & Technology

Valuation: Avinger, Inc.

Latest news : Avinger, Inc.

Analysts' recommendations: Avinger, Inc.

Press Releases: Avinger, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Avinger, Inc.

Latest insider transactions

Medical Imaging Systems

Financials

Company Profile

Income Statement and Estimates

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/23/25	Jeffrey Soinski	Sell	Chief Executive Officer	3,690	0.1115%
1/23/25	Himanshu Patel	Sell	Founder	2,215	0.0669%
1/23/25	Nabeel Subainati	Sell	Chief Financial Officer	1,255	0.0379%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AVINGER, INC.	-20.74%	-.--%	-.--%	-96.39%	1.52M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD.	+0.01%	+4.45%	-14.78%	-16.59%	13.79B
IRAY GROUP	+1.52%	-8.34%	+40.09%	-8.60%	3.89B
IRADIMED CORPORATION	-0.23%	+0.26%	+66.71%	+103.29%	1.2B
SONOSCAPE MEDICAL CORP.	-3.05%	-2.34%	-38.13%	-60.52%	1.21B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD.	+0.19%	-2.78%	-41.32%	-47.39%	1.09B
SHANTOU INSTITUTE OF ULTRASONIC INSTRUMENT CO., LTD.	+0.34%	+2.35%	-42.93%	-	934M
CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD.	+2.37%	-14.11%	+49.28%	+79.71%	457M
CAPSOVISION, INC.	-4.49%	+4.27%	+50.00%	-	345M
FISCHER MEDICAL VENTURES LIMITED	-0.21%	+0.88%	-58.49%	+234.80%	262M
Average	-2.43%	+3.03%	+1.04%	+23.54%	2.32B
Weighted average by Cap.	+0.09%	+2.21%	-3.22%	-7.54%

	2022	2023
Net sales	8.27M 7.28M 6.76M 6.22M 11.66M 801M 11.87M 80.83M 31.53M 391M 31.06M 30.39M 1.36B	7.65M 6.73M 6.25M 5.75M 10.78M 741M 10.98M 74.76M 29.16M 361M 28.73M 28.11M 1.25B
Net income	-17.62M -15.5M -14.4M -13.24M -24.84M -1.71B -25.28M -172M -67.16M -832M -66.16M -64.73M -2.89B	-18.32M -16.11M -14.97M -13.77M -25.82M -1.77B -26.28M -179M -69.82M -865M -68.78M -67.29M -3B
Net Debt	1.76M 1.54M 1.43M 1.32M 2.47M 170M 2.52M 17.16M 6.69M 82.95M 6.59M 6.45M 288M	10.12M 8.9M 8.27M 7.6M 14.26M 980M 14.52M 98.88M 38.57M 478M 37.99M 37.17M 1.66B

3 years	0.36	14
5 years	0.36	312
10 years	0.36	746,402.99